Across
- 4. neutropenia is defined as an _______ of less than 1.5
- 5. This drug can lead to hemorrhagic cystitis in high doses
- 6. new expanded cord blood cellular therapy product that we did for the first time this nurse's week
- 9. acronym used to describe the most common symptoms in multiple myeloma
- 12. cryoprotectant utilized to maintain cellular therapy products frozen prior to infusion
- 14. accrediting body for Blood and Marrow Transplant
- 17. IL-6 receptor inhibitor given to treat symptoms of CRS after CART
- 18. extracorporeal __________ is a type of treatment utilized for chronic GVHD of the skin and lungs that requires a special central venous line.
- 20. closed system transfer device used to protect yourself when administering chemotherapy/immunotherapy
Down
- 1. you should never flush/push this drug due to the chance of reaction
- 2. __________ stem cells are the "mother ship" of all cells which then differentiate into your remaining blood cells
- 3. __________ t cell engagers are a type of cellular therapy used to treat relapsed and refractory hematologic malignancies
- 7. a condition that can occur after an allogeneic stem cell transplant when the donor cells recognize the recipient as foreign
- 8. can be reactivated in the recipient after transplant, and is responsible for conditions such as PTLD, Hodgkin Lymphoma, and HLH
- 10. immunotherapy that targets CD20+ cells in B cell lymphomas
- 11. type of immunotherapy that uses genetically engineered autologous T cells to target CD19+ B cells
- 13. most common treatment of acute and chronic GVHD which can lead to complications such as hyperglycemia, osteoporosis, and mood changes
- 15. tumor lysis labs should be ordered when the patient initiates this oral chemotherapy drug
- 16. rescue medication given after high dose methotrexate infusion
- 19. Central line dressings are changed every ______ days or as needed